Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients
Authors:
- Frank M. SacksFSFrank M. Sacks
- Lemuel A. MoyéLMLemuel A. Moyé
- Lisa BrownLBLisa Brown
- Jean L. RouleauJRJean L. Rouleau
- L. Howard HartleyLHL. Howard Hartley
- Jacques RouleauJRJacques Rouleau
- Richard GrimmRGRichard Grimm
- Francois SestierFSFrancois Sestier
- William WickemeyerWWWilliam Wickemeyer
- Thomas G. ColeTCThomas G. Cole
- Eugene BraunwaldEBEugene Braunwald
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (9) , 98C-106C
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cholesterol reduction and its impact on coronary artery disease and total mortalityThe American Journal of Cardiology, 1995
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levelsThe American Journal of Cardiology, 1995
- Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery diseaseJACC, 1992
- Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)The American Journal of Cardiology, 1991
- Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with HypercholesterolemiaNew England Journal of Medicine, 1990
- Background of the prevention of cardiovascular disease. II. Arteriosclerosis, hypertension, and selected risk factors.Circulation, 1989
- Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic AcidActa Medica Scandinavica, 1988
- Ischaemic Heart Disease: A Secondary Prevention Trial Using ClofibrateBMJ, 1971
- Trial of Clofibrate in the Treatment of Ischaemic Heart Disease: FIVE-YEAR STUDY BY A GROUP OF PHYSICIANS OF THE NEWCASTLE UPON TYNE REGIONBMJ, 1971